Ausgabe 9/2020
Inhalt (9 Artikel)
Providing optimal interventional oncology procedures at one of the COVID-19 referral center in Italy
Filippo Pesapane, Anna Maria Ierardi, Antonio Arrichiello, Gianpaolo Carrafiello
Considerations in treating patients with advance lung cancer during the epidemic outbreak of novel coronavirus (SARS-CoV-2)
Yangyang Cai, Yinghui Xu, Dongsheng Xu, Yizhuo Wang, Xu Wang, Chao Sun, Ye Guo, Shi Qiu, Kewei Ma
Original Paper
Comprehensive analysis of location-specific hub genes related to the pathogenesis of colon cancer
Cheng Shi, Ke Ding, Ke-zhi Li, Long Long, Ji-lin Li, Bang-li Hu
Original Paper
Identification of biomarkers associated with extracellular vesicles based on an integrative pan-cancer bioinformatics analysis
Qiang Wang, Chaoran Yu
Original Paper
What is the damage? Testicular germ cell tumour survivors deficient in testosterone at risk of metabolic syndrome and a need for medical intervention
Grazyna Poniatowska, Wojciech Michalski, Jakub Kucharz, Joanna Jonska-Gmyrek, Paulina Wieszczy, Karol Nietupski, Tomasz Demkow, Marek Dedecjus, Malgorzata Sadowska, Tomasz Kalinowski, Beata Grochulska-Nalazek, Ada Nowatorska, Pawel Stelmasiak, Pawel J. Wiechno
Original Paper
RNA-binding protein Musashi2 regulates Hippo signaling via SAV1 and MOB1 in pancreatic cancer
Haiyan Yang, Jiong Hu, Jingde Chen, Zhiqin Chen, Feng Jiao, Jiujie Cui, Ming Quan, Liwei Wang
COVID-19 and cancer care: what do international guidelines say?
Alfredo Tartarone, Rosa Lerose
Short Communication
Treating metastatic clear-cell renal cell carcinoma: beyond immunotherapy
Gianluca Perego, Paolo Barzaghi, Ivano Vavassori, Fausto Petrelli
Face masks in radiation oncology clinics: based on evidence or source of mistakes?
Rainer J. Klement, Reinhart A. Sweeney